BBIO
BridgeBio Pharma Inc
66.30$
+0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | -5.8% | +1,160.4% | +0.0% | +89.2% | +15.9% | -4.1% | -6.5% | -1.8% | |
| – | +229.5% | +252.3% | +173.5% | +70.2% | -8.0% | +25.6% | -16.7% | +38.9% | |
| – | – | – | +249.0% | +77.7% | +1.4% | – | – | – | |
| – | +1,709.4% | -148.5% | – | -129.4% | – | -82.0% | +533.6% | -259.4% | |
| – | +3,817.7% | -71.7% | +46.3% | +541.7% | -86.9% | -79.3% | -28.6% | +17.6% | |
| – | +4,433.6% | +932.8% | -75.6% | +279.0% | – | -88.1% | +12.5% | -140.3% | |
| – | -100.0% | – | +53,757.7% | -99.3% | – | – | – | – | |
| – | +302.2% | -14.4% | -120.5% | +170.4% | -99.2% | +340.7% | +9.4% | +541.5% | |
| – | +1,308.5% | -34.4% | +1,353.6% | +98.1% | -101.9% | -100.0% | – | -75.7% | |
| – | +343.9% | -20.5% | +12.1% | +64.7% | -101.8% | – | +65.8% | -52.0% | |
| – | +377.4% | -121.0% | – | – | -45.6% | -208.0% | – | -138.5% | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.